RBDSARS-CoV-2:

Yasamin Pahlavan1, Omid Yeganeh2, Vahid Asghariazar3

  • 1Biosensor Sciences and Technologies Research Center, Ardabil University of Medical Sciences, Ardabil, 56189-85991, Iran.

Future science OA
|June 3, 2024
PubMed
概括

这项研究使用尖端蛋白的受体结合域 (RBD) 设计了一种SARS-CoV-2表位疫苗. 预测的表位表现出高的免疫性,这表明潜在的有效的多表位疫苗对抗COVID-19.